{"id":"https://openalex.org/W4394347207","doi":"https://doi.org/10.6084/m9.figshare.14714909","title":"Silencing PEX26 as an Unconventional Mode to Kill Drug-Resistant Cancer Cells and Forestall Drug Resistance","display_name":"Silencing PEX26 as an Unconventional Mode to Kill Drug-Resistant Cancer Cells and Forestall Drug Resistance","publication_year":2021,"publication_date":"2021-01-01","ids":{"openalex":"https://openalex.org/W4394347207","doi":"https://doi.org/10.6084/m9.figshare.14714909"},"language":"en","primary_location":{"id":"pmh:oai:figshare.com:article/14714909","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Silencing_PEX26_as_an_Unconventional_Mode_to_Kill_Drug-Resistant_Cancer_Cells_and_Forestall_Drug_Resistance/14714909","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},"volume":null,"type":"dataset","indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://figshare.com/articles/dataset/Silencing_PEX26_as_an_Unconventional_Mode_to_Kill_Drug-Resistant_Cancer_Cells_and_Forestall_Drug_Resistance/14714909","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068432485","display_name":"Michael S. Dahabieh","orcid":"https://orcid.org/0000-0002-2518-7129","observed_orcids":["https://orcid.org/0000-0002-2518-7129"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dahabieh, Michael S.","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020543727","display_name":"Fan Huang","orcid":"https://orcid.org/0000-0002-3850-5317","observed_orcids":["https://orcid.org/0000-0002-3850-5317"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Huang, Fan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019238945","display_name":"Christophe Gon\u00e7alves","orcid":"https://orcid.org/0000-0003-2660-1616","observed_orcids":["https://orcid.org/0000-0003-2660-1616"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Goncalves, Christophe","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039614060","display_name":"Ra\u00fal Ernesto Flores Gonz\u00e1lez","orcid":"https://orcid.org/0009-0001-9745-680X","observed_orcids":["https://orcid.org/0009-0001-9745-680X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gonz\u00e1lez, Ra\u00fal Ernesto Flores","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003376094","display_name":"Sathyen Alwin Prabhu","orcid":"https://orcid.org/0000-0001-8088-5168","observed_orcids":["https://orcid.org/0000-0001-8088-5168"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Prabhu, Sathyen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066952730","display_name":"Alicia M. Bolt","orcid":"https://orcid.org/0000-0003-1936-4851","observed_orcids":["https://orcid.org/0000-0003-1936-4851"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bolt, Alicia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011089966","display_name":"Erminia Di Pietro","orcid":"https://orcid.org/0009-0004-2645-6732","observed_orcids":["https://orcid.org/0009-0004-2645-6732"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Di Pietro, Erminia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Khoury, Elie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Khoury, Elie","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Heath, John","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Heath, John","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049654532","display_name":"Ziyi Xu","orcid":"https://orcid.org/0000-0001-7221-8568","observed_orcids":["https://orcid.org/0000-0001-7221-8568"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xu, Zi Yi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019837180","display_name":"Joelle R\u00e9my-Sarrazin","orcid":"https://orcid.org/0000-0002-3081-3307","observed_orcids":["https://orcid.org/0000-0002-3081-3307"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R\u00e9my-Sarrazin, Joelle","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041219905","display_name":"Koren Kathleen Mann","orcid":"https://orcid.org/0000-0003-3366-1123","observed_orcids":["https://orcid.org/0000-0003-3366-1123"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mann, Koren K.","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024623853","display_name":"Alexandre Orthwein","orcid":"https://orcid.org/0000-0002-7350-3413","observed_orcids":["https://orcid.org/0000-0002-7350-3413"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Orthwein, Alexandre","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041114334","display_name":"Fran\u00e7ois\u2010Michel Boisvert","orcid":"https://orcid.org/0000-0001-8882-8619","observed_orcids":["https://orcid.org/0000-0001-8882-8619"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Boisvert, Fran\u00e7ois-Michel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070970254","display_name":"Nancy Braverman","orcid":"https://orcid.org/0000-0003-1621-5164","observed_orcids":["https://orcid.org/0000-0003-1621-5164"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Braverman, Nancy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048013287","display_name":"Wilson H. Miller","orcid":"https://orcid.org/0000-0002-7408-1574","observed_orcids":["https://orcid.org/0000-0002-7408-1574"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Miller, Wilson H.","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5089111286","display_name":"Sonia Victoria Del Rincon","orcid":"https://orcid.org/0000-0002-6350-0227","observed_orcids":["https://orcid.org/0000-0002-6350-0227"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"del Rinc\u00f3n, Sonia V.","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10587","display_name":"Autophagy in Disease and Therapy","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10587","display_name":"Autophagy in Disease and Therapy","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pexophagy","display_name":"pexophagy","score":0.906000018119812},{"id":"https://openalex.org/keywords/autophagy","display_name":"autophagy","score":0.7839999794960022},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.8090000152587891},{"id":"https://openalex.org/keywords/ataxia-telangiectasia-mutated","display_name":"ATM kinase","score":0.5979999899864197},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.5889999866485596},{"id":"https://openalex.org/keywords/lymphoma","display_name":"lymphoma","score":0.609000027179718},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.5720000267028809},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7950000166893005},{"id":"https://openalex.org/keywords/mtor","display_name":"mTOR","score":0.6470000147819519},{"id":"https://openalex.org/keywords/pex6","display_name":"PEX6","score":0.5630000233650208},{"id":"https://openalex.org/keywords/pex1","display_name":"PEX1","score":0.7590000033378601},{"id":"https://openalex.org/keywords/crispr-interference","display_name":"CRISPR interference","score":0.7760000228881836},{"id":"https://openalex.org/keywords/tumor-recurrence","display_name":"tumor recurrence","score":0.42899999022483826},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.5609999895095825}],"concepts":[{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.6479224562644958},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6319947242736816},{"id":"https://openalex.org/C3020340455","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Cancer drugs","level":3,"score":0.6276490688323975},{"id":"https://openalex.org/C119056186","wikidata":"https://www.wikidata.org/wiki/Q1431332","display_name":"Gene silencing","level":3,"score":0.5930227041244507},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4496840834617615},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.39754390716552734},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2611956298351288},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.17227709293365479},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.16010832786560059},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.06880035996437073}],"mesh":[],"locations_count":3,"locations":[{"id":"pmh:oai:figshare.com:article/14714909","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Silencing_PEX26_as_an_Unconventional_Mode_to_Kill_Drug-Resistant_Cancer_Cells_and_Forestall_Drug_Resistance/14714909","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},{"id":"doi:10.6084/m9.figshare.14714909","doi":"https://doi.org/10.6084/m9.figshare.14714909","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.14714909","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Dataset"},{"id":"doi:10.6084/m9.figshare.14714909.v1","doi":"https://doi.org/10.6084/m9.figshare.14714909.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.14714909.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Dataset"}],"best_oa_location":{"id":"pmh:oai:figshare.com:article/14714909","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Silencing_PEX26_as_an_Unconventional_Mode_to_Kill_Drug-Resistant_Cancer_Cells_and_Forestall_Drug_Resistance/14714909","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2737725258","https://openalex.org/W4307590012","https://openalex.org/W4394786883","https://openalex.org/W4386117213","https://openalex.org/W7215811898","https://openalex.org/W4409409288","https://openalex.org/W7163354109","https://openalex.org/W2273515495","https://openalex.org/W2558729727","https://openalex.org/W2797612554"],"abstract_inverted_index":{"Promoting":[0],"the":[1,60,164],"macroautophagy/autophagy-mediated":[2],"degradation":[3],"of":[4,59,81,110,133,166,177,186,305],"specific":[5],"proteins":[6],"and":[7,41,137,189,202],"organelles":[8],"can":[9],"potentially":[10],"be":[11],"utilized":[12],"to":[13,23,95,117,160,168,211,220],"induce":[14],"apoptosis":[15],"in":[16,75,198,224],"cancer":[17,201],"cells":[18,22,40,53,77,94,116,126],"or":[19,57,88,267],"sensitize":[20],"tumor":[21,66],"therapy.":[24,173],"To":[25,68],"examine":[26],"this":[27],"concept,":[28],"we":[29,72],"enriched":[30],"for":[31],"autophagosomes":[32],"from":[33],"histone":[34,271],"deacetylase":[35,272],"inhibitor":[36],"(HDACi)-sensitive":[37],"U937":[38],"lymphoma":[39],"isogenic":[42],"HDACi-resistant":[43,52,76],"cells.":[44],"Mass":[45],"spectrometry":[46],"on":[47],"autophagosome-enriched":[48],"fractions":[49],"revealed":[50],"that":[51,64,153,182,208],"undergo":[54],"elevated":[55],"pexophagy,":[56],"autophagy":[58],"peroxisome,":[61],"an":[62],"organelle":[63],"supports":[65],"growth.":[67],"disturb":[69],"peroxisome":[70,82,213,309],"homeostasis,":[71],"enhanced":[73],"pexophagy":[74,136],"via":[78],"genetic":[79],"silencing":[80],"exportomer":[83],"complex":[84],"components":[85],"(PEX1,":[86],"PEX6,":[87],"PEX26).":[89],"This":[90],"consequently":[91],"sensitized":[92],"resistant":[93],"HDACi-mediated":[96],"apoptosis,":[97],"which":[98],"was":[99],"rescued":[100],"by":[101],"inhibiting":[102],"ATM/ataxia-telangiectasia":[103],"mutated":[104],"(ATM":[105],"serine/threonine":[106],"kinase),":[107],"a":[108],"mediator":[109],"pexophagy.":[111],"We":[112],"subsequently":[113],"engineered":[114],"melanoma":[115,155,203],"stably":[118],"repress":[119],"PEX26":[120,129],"using":[121],"CRISPR":[122],"interference":[123],"(CRISPRi).":[124],"Melanoma":[125],"with":[127,194],"repressed":[128],"expression":[130,184],"showed":[131,152,181],"evidence":[132],"both":[134],"increased":[135],"peroxisomal":[138,313],"matrix":[139],"protein":[140,170,280,296],"import":[141],"defects":[142],"versus":[143],"single":[144,322],"guide":[145,323],"scrambled":[146],"(sgSCR)":[147],"controls.":[148],"In":[149],"vivo":[150],"studies":[151],"sgPEX26":[154],"xenografts":[156],"recurred":[157],"less":[158],"compared":[159],"sgSCR":[161],"xenografts,":[162],"following":[163],"development":[165],"resistance":[167,223],"mitogen-activated":[169],"kinase":[171],"(MAPK)-targeted":[172],"Finally,":[174],"prognostic":[175],"analysis":[176],"publicly":[178],"available":[179],"datasets":[180],"low":[183],"levels":[185],"PEX26,":[187],"PEX6":[188],"MTOR,":[190],"were":[191],"significantly":[192],"associated":[193,278,295],"prolonged":[195],"patient":[196],"survival":[197],"lymphoma,":[199],"lung":[200],"cohorts.":[204],"Our":[205],"work":[206],"highlighted":[207],"drugs":[209],"designed":[210],"disrupt":[212],"homeostasis":[214],"may":[215],"serve":[216],"as":[217],"unconventional":[218],"therapies":[219],"combat":[221],"therapy":[222],"cancer.":[225],"Abbreviations:":[226],"ABCD3/PMP70:":[227],"ATP":[228],"binding":[229],"cassette":[230],"subfamily":[231],"D":[232],"member":[233],"3;":[234],"ACOX1:":[235],"acyl-CoA":[236],"oxidase":[237],"1;":[238,316],"AP:":[239],"autophagosome;":[240],"COX:":[241],"cytochrome":[242],"c":[243],"oxidase;":[244],"CQ:":[245],"chloroquine;":[246],"CRISPRi:":[247],"clustered":[248],"regularly":[249],"interspaced":[250],"short":[251],"palindromic":[252],"repeats":[253],"interference;":[254],"DLBCL:":[255],"diffuse":[256],"large":[257],"B-cell":[258],"lymphoma;":[259],"GO:":[260],"gene":[261],"ontology;":[262],"dCas9:":[263],"Cas9":[264],"endonuclease":[265],"dead,":[266],"dead":[268],"Cas9;":[269],"HDACi:":[270],"inhibitors;":[273],"IHC:":[274],"Immunohistochemistry;":[275],"LAMP2:":[276],"lysosomal":[277],"membrane":[279],"2;":[281],"LCFAs:":[282],"long-chain":[283],"fatty":[284,328],"acids;":[285,329],"LFQ-MS:":[286],"label-free":[287],"quantitation":[288],"mass":[289],"spectrometry;":[290],"LPC:":[291],"lysophoshatidylcholine;":[292],"MAP1LC3B/LC3B:":[293],"microtubule":[294],"1":[297],"light":[298],"chain":[299,327],"3":[300],"beta;":[301],"MTOR:":[302],"mechanistic":[303],"target":[304],"rapamycin":[306],"kinase;":[307],"PBD:":[308],"biogenesis":[310],"disorders;":[311],"PTS1:":[312],"targeting":[314],"signal":[315],"ROS:":[317],"reactive":[318],"oxygen":[319],"species;":[320],"sgRNA:":[321],"RNA;":[324],"VLCFAs:":[325],"very-long":[326],"Vor:":[330],"vorinostat;":[331],"WO:":[332],"wash-off.":[333]},"counts_by_year":[],"updated_date":"2026-10-13T10:08:12.033832","created_date":"2024-04-08T00:00:00"}